Pharmacogenetics of CYP2A6 , CYP2B6 , and UGT2B7 in the Context of HIV Treatments in African Populations.
Graeme R FordAntoinette NiehausFourie JoubertMichael Sean PepperPublished in: Journal of personalized medicine (2022)
This study describes allele frequencies observed in African populations at significantly different frequencies relative to at least one other reference population and identifies a subset of variants of clinical interest. Despite the inclusion of mixed sequence coverage datasets, the variants identified pose notable avenues for future inquiries. A subset of variants of clinical interest with statistically significant inter-population frequency differences was identified for further inspection, which provides evidence of an African population-specific variant frequency profile. This study highlights the need for additional research and African genetics data given the presence of this unique frequency profile to better facilitate the genetic pre-screening of patients as a standard of practice in HIV care, particularly on the African continent where HIV is highly prevalent.
Keyphrases
- copy number
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hepatitis c virus
- hiv testing
- genome wide
- end stage renal disease
- hiv aids
- healthcare
- newly diagnosed
- primary care
- men who have sex with men
- chronic kidney disease
- dna methylation
- gene expression
- current status
- prognostic factors
- deep learning
- big data
- health insurance
- amino acid
- patient reported outcomes